Reinhard Dummer

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 17 papers. Top paper: “Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma”.

Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma

European Journal of Cancer(2020)10.1016/j.ejca.2020.11.010

N/A

3.9DataRank · unranked

100 citations

Wen-Jen Hwu, Omid Hamid, Antoni Ribas, Jeffrey S. Weber, Adil Daud +18 more

Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs

Chemical Immunology and Allergy(2012)10.1159/000335632

N/A

2.1DataRank · unranked

29 citations

Nicola Schönewolf, Sima Rozati, Simone M. Goldinger, Reinhard Dummer, Benedetta Belloni

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

New England Journal of Medicine(2015)10.1056/nejmoa1504030

N/A

1.3DataRank · unranked

8085 citations

Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C. Lance Cowey, Christopher D. Lao +35 more

Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study

European Journal of Cancer(2020)10.1016/j.ejca.2020.04.010

N/A

1.3DataRank · unranked

30 citations

H. Miles Prince, Sean Whittaker, Sarah McCue Horwitz, Youn H. Kim, Julia Scarisbrick +22 more

MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patients

European Journal of Cancer(2018)10.1016/j.ejca.2018.04.010

N/A

0.635DataRank · unranked

68 citations

Selma Ugurel, Johanna Mangana, Markus Valentin Heppt, Thomas Kurt Eigentler, Carola Berking +5 more

Targeting PHGDH Upregulation Reduces Glutathione Levels and Resensitizes Resistant NRAS-Mutant Melanoma to MAPK Kinase Inhibition

Journal of Investigative Dermatology(2020)10.1016/j.jid.2020.02.047

N/A

0DataRank · unranked

43 citations

Jessica L.F. Teh, Timothy J. Purwin, Inna Chervoneva, Michael A. Davies, Katherine L. Nathanson +5 more

Activation of CD8+ T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors

Cancer Immunology Research(2020)10.1158/2326-6066.cir-19-0743

N/A

0DataRank · unranked

20 citations

Dan A. Erkes, Phil F. Cheng, Manoela Tiago, Nicole A. Wilski, Conroy O. Field +6 more

SPANX Control of Lamin A/C Modulates Nuclear Architecture and Promotes Melanoma Growth

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-20-0291

N/A

0DataRank · unranked

20 citations

Bertrand Fabre, Yongmei Feng, Ali Khateb, Patrick Turko, Julia M. Martínez Gómez +19 more

Sustained Androgen Receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.26.116665

N/A

0DataRank · unranked

6 citations

Soumitra Ghosh, Daniele Tavernari, Atul Katarkar, Andrea Clocchiatti, Luigi Mazzeo +10 more

A multicentre study of naevus‐associated melanoma vs. de novo melanoma, tumour thickness and body site differences*

British Journal of Dermatology(2021)10.1111/bjd.19819

N/A

0DataRank · unranked

26 citations

Alan C. Geller, A. Stergiopoulou, Niki Dimou, Serigne Lo, Ulrike Keim +17 more

A DNA Replication-Independent Function of the pre-Replication Complex during Cell Invasion in C. elegans

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.10.447853

N/A

0DataRank · unranked

0 citations

Ting Deng, Michael Walser, Patrizia Widmer, Charlotte Rexha-Lambert, Vibhu Prasad +6 more

A DNA replication-independent function of pre-replication complex genes during cell invasion in C. elegans

PLoS Biology(2022)10.1371/journal.pbio.3001317

N/A

0DataRank · unranked

12 citations

Ting Deng, Michael Walser, Patrizia Widmer, Charlotte Rexha-Lambert, Vibhu Prasad +6 more

Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma

Annals of Surgical Oncology(2023)10.1245/s10434-023-13570-9

N/A

0DataRank · unranked

1 citations

John Hyngstrom, Corrado Caracò, Jonathan S. Zager, Tiina Jahkola, Tawnya L. Bowles +42 more

The genetic evolution of acral melanoma

Nature Communications(2024)10.1038/s41467-024-50233-z

N/A

0DataRank · unranked

37 citations

Satoshi Fukushima, Yi‐Shuan Sheen, Egle Ramelyte, Noel Cruz‐Pacheco, Chenxu Shi +12 more

Differential histone acetylation and super-enhancer regulation underlie melanoma cell dedifferentiation

JCI Insight(2024)10.1172/jci.insight.166611

N/A

0DataRank · unranked

5 citations

Tiphaine Martin, Christie B. Nguyen, Min Hsu, Jia Xu, Claudia Lang +10 more

Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis

The Journal of Experimental Medicine(2020)10.1084/jem.20201137

N/A

0DataRank · unranked

57 citations

Soumitra Ghosh, Daniele Tavernari, Atul Katarkar, Andrea Clocchiatti, Luigi Mazzeo +10 more

International real-world study of combination immunotherapy sequences in metastatic melanoma

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012225

N/A

0DataRank · unranked

0 citations

Sarah E. Lochrin, James W. Smithy, Michael A. Postow, Caroline Gaudy‐Marqueste, Nausicaa Malissen +28 more